Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern

scientific article published on March 2008

Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1016/S1473-3099(08)70041-0
P698PubMed publication ID18291338
P5875ResearchGate publication ID5561532

P50authorKevin LauplandQ87139465
P2093author name stringJohann D D Pitout
P2860cites workThe changing epidemiology of Staphylococcus aureus?Q22305657
Extended-spectrum beta-lactamases: a clinical updateQ24534999
Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threatQ24550671
The CTX-M beta-lactamase pandemic.Q30356558
Community-wide outbreaks of clonally related CTX-M-14 beta-lactamase-producing Escherichia coli strains in the Calgary health regionQ33856392
Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory.Q33972587
Molecular detection of antimicrobial resistanceQ33975793
Use of microdilution panels with and without beta-lactamase inhibitors as a phenotypic test for beta-lactamase production among Escherichia coli, Klebsiella spp., Enterobacter spp., Citrobacter freundii, and Serratia marcescens.Q33976916
Rapid discriminatory detection of genes coding for SHV beta-lactamases by ligase chain reactionQ33980007
Real-time PCR and melting curve analysis for reliable and rapid detection of SHV extended-spectrum beta-lactamasesQ33982263
Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing EnterobacteriaceaeQ33983667
The new beta-lactamases.Q33984601
Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcomeQ34106854
Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs).Q34135508
Controversies about extended-spectrum and AmpC beta-lactamasesQ34213755
CTX-M-type extended-spectrum beta-lactamases in Italy: molecular epidemiology of an emerging countrywide problemQ34973754
Growing group of extended-spectrum beta-lactamases: the CTX-M enzymesQ35006613
Identification of CTX-M-type extended-spectrum-beta-lactamase genes using real-time PCR and pyrosequencingQ35635686
Modification of the double-disk test for detection of enterobacteriaceae producing extended-spectrum and AmpC beta-lactamasesQ35638321
Cefotaximases (CTX-M-ases), an expanding family of extended-spectrum beta-lactamasesQ35754705
Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary Health Region: emergence of CTX-M-15-producing isolatesQ35758933
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatmentQ35840852
Genetic methods for detection of antimicrobial resistanceQ36003062
Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the communityQ36139832
Molecular detection of antibiotic resistance: when and where?Q36169044
Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of AmericaQ36382134
Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients.Q36598540
CTX-M: changing the face of ESBLs in EuropeQ36678524
Rapid detection and identification of bacterial pathogens using novel molecular technologies: infection control and beyondQ36700241
Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized studyQ36880729
Phenotypic and molecular detection of CTX-M-beta-lactamases produced by Escherichia coli and Klebsiella sppQ37702466
Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolatesQ38475591
Discrimination of SHV beta-lactamase genes by restriction site insertion-PCRQ39477822
Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniaeQ42167308
CTX-M-type beta-lactamases affect community Escherichia coli treatment, GreeceQ42551507
bla(CTX-M) genes in clinical Salmonella isolates recovered from humans in England and Wales from 1992 to 2003.Q42708799
Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection proceduresQ42799124
Evaluation of a new selective chromogenic agar medium for detection of extended-spectrum beta-lactamase-producing EnterobacteriaceaeQ42912527
Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infectionQ43843241
Bacteremia caused by Escherichia coli producing extended-spectrum beta-lactamase: a case-control study of risk factors and outcomesQ44142354
Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomesQ44436393
Detection of antimicrobial resistance by small rural hospital microbiology laboratories: comparison of survey responses with current NCCLS laboratory standardsQ44580618
Clinical and Microbiologic Analysis of a Hospital's Extended‐Spectrum β‐Lactamase‐Producing Isolates Over a 2‐Year PeriodQ44640091
Bacteremia due to Klebsiella pneumoniae isolates producing the TEM-52 extended-spectrum beta-lactamase: treatment outcome of patients receiving imipenem or ciprofloxacinQ44709393
Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamasesQ44943295
Population-based laboratory surveillance for Escherichia coli-producing extended-spectrum beta-lactamases: importance of community isolates with blaCTX-M genesQ44959090
Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK.Q45044150
Detection and characterization of extended-spectrum beta-lactamases among bloodstream isolates of Enterobacter spp. in Hong Kong, 2000-2002.Q45244902
A novel reverse-line hybridization assay for identifying genotypes of CTX-M-type extended-spectrum beta-lactamases.Q50700097
Bacterial resistance: origins, epidemiology, and impact.Q52282006
Evolution and clinical importance of extended-spectrum beta-lactamases.Q54021930
In vivo selection of a cephamycin-resistant, porin-deficient mutant of Klebsiella pneumoniae producing a TEM-3 beta-lactamase.Q54354740
Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge.Q54452583
Outcome of cephalosporin treatment of bacteremia due to CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli.Q54457021
Performance in detection and reporting beta-lactam resistance phenotypes in Enterobacteriaceae: a nationwide proficiency study in Italian laboratories.Q54465752
Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum (beta)-lactamases.Q54631687
Treatment of lower urinary tract infection caused by multidrug-resistant extended-spectrum- -lactamase-producing Escherichia coli with amoxicillin/clavulanate: case report and characterization of the isolateQ58866123
Detection of mutations conferring extended-spectrum activity on SHV beta-lactamases using polymerase chain reaction single strand conformational polymorphism (PCR-SSCP)Q71299726
Clinical implications of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteraemiaQ78408808
Real-time TaqMan PCR for rapid detection and typing of genes encoding CTX-M extended-spectrum beta-lactamasesQ79436347
Development and clinical validation of a molecular diagnostic assay to detect CTX-M-type beta-lactamases in EnterobacteriaceaeQ80055058
Treatment of ESBL-producing Klebsiella pneumoniae bacteraemia with carbapenems or flomoxef: a retrospective study and laboratory analysis of the isolatesQ80258308
Influx of extended-spectrum beta-lactamase-producing enterobacteriaceae into the hospitalQ82703807
P433issue3
P921main subjectpublic healthQ189603
EnterobacteriaceaeQ380136
P304page(s)159-166
P577publication date2008-03-01
P1433published inLancet Infectious DiseasesQ15724248
P1476titleExtended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern
P478volume8

Reverse relations

cites work (P2860)
Q92635807A High Resolution DNA Melting Curve Analysis for the Rapid and Efficient Molecular Diagnostics of Extended Spectrum β-Lactamase Determinants from Foodborne Escherichia coli
Q37023191A Multinational, Preregistered Cohort Study of β-Lactam/β-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae
Q94140236A Programmable Digital Microfluidic Assay for the Simultaneous Detection of Multiple Anti-Microbial Resistance Genes
Q40083163A Role for FimH in Extraintestinal Pathogenic Escherichia coli Invasion and Translocation through the Intestinal Epithelium
Q40050797A comparison of blood stream infections with extended spectrum beta-lactamase-producing and non-producing Klebsiella pneumoniae in pediatric patients.
Q35086954A degenerate PCR-based strategy as a means of identifying homologues of aminoglycoside and β-lactam resistance genes in the gut microbiota.
Q40954637A new mechanism to render clinical isolates of Escherichia coli non-susceptible to imipenem: substitutions in the PBP2 penicillin-binding domain
Q21131083A new strategy to fight antimicrobial resistance: the revival of old antibiotics
Q89821618A pilot study using environmental screening to determine the prevalence of Mycobacterium avium subspecies paratuberculosis (MAP) and antimicrobial resistance (AMR) in Irish cattle herds
Q30986331A qPCR and multiplex pyrosequencing assay combined with automated data processing for rapid and unambiguous detection of ESBL-producers Enterobacteriaceae
Q33606193A simple scoring algorithm predicting extended-spectrum β-lactamase producers in adults with community-onset monomicrobial Enterobacteriaceae bacteremia: Matters of frequent emergency department users
Q35607484A statistical approach for determination of disk diffusion-based cutoff values for systematic characterization of wild-type and non-wild-type bacterial populations in antimicrobial susceptibility testing
Q34398603A step towards the discrimination of beta-lactamase-producing clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa by MALDI-TOF mass spectrometry.
Q90038693A survey of extended-spectrum beta-lactamase-producing Enterobacteriaceae in urban wetlands in southwestern Nigeria as a step towards generating prevalence maps of antimicrobial resistance
Q40912929A trial with IgY chicken antibodies to eradicate faecal carriage of Klebsiella pneumoniae and Escherichia coli producing extended-spectrum beta-lactamases
Q35848981Activity of Fosfomycin against Extended-Spectrum-β-Lactamase-Producing Uropathogens in Patients in the Community and Hospitalized Patients
Q34932937Activity of NXL104 in combination with beta-lactams against genetically characterized Escherichia coli and Klebsiella pneumoniae isolates producing class A extended-spectrum beta-lactamases and class C beta-lactamases.
Q40735145Activity of temocillin in a lethal murine model of infection of intra-abdominal origin due to KPC-producing Escherichia coli
Q41559832Activity of temocillin in a murine model of urinary tract infection due to Escherichia coli producing or not producing the ESBL CTX-M-15.
Q53731306Activity of the novel siderophore cephalosporin cefiderocol against multidrug-resistant Gram-negative pathogens.
Q46304823Age-Related Trends in Adults with Community-Onset Bacteremia
Q59790104Alarming levels of antimicrobial resistance among sepsis patients admitted to ICU in a tertiary care hospital in India - a case control retrospective study
Q37455103Alterations in antibiotic susceptibility of urinary tract infection pathogens.
Q36933507Amino Acid Substitutions of CrrB Responsible for Resistance to Colistin through CrrC in Klebsiella pneumoniae
Q35805673Aminoglycoside therapy for childhood urinary tract infection due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae
Q51035217Amoxicillin plus clavulanic acid versus appendicectomy for treatment of acute uncomplicated appendicitis: an open-label, non-inferiority, randomised controlled trial.
Q53552462Amperometric detection of extended-spectrum β-lactamase activity: application to the characterization of resistant E. coli strains.
Q51298402An abbreviated MLVA identifies Escherichia coli ST131 as the major extended-spectrum β-lactamase-producing lineage in the Copenhagen area.
Q64978675An evaluation of multidrug-resistant Escherichia coli isolates in urinary tract infections from Aguascalientes, Mexico: cross-sectional study.
Q51275947An evolutionarily conserved allosteric site modulates beta-lactamase activity.
Q42238142An outbreak of CTX-M-15 -producing Escherichia coli, Enterobacter cloacae, and Klebsiella in a children's hospital in Finland
Q38724222Analysis of bla(CTX-M)-carrying plasmids from Escherichia coli isolates collected in the BfT-GermVet study
Q35843272Antibacterial Effects and Mode of Action of Selected Essential Oils Components against Escherichia coli and Staphylococcus aureus.
Q43940593Antibacterial activity and synergistic effect between watercress extracts, 2-phenylethyl isothiocyanate and antibiotics against 11 isolates of Escherichia coli from clinical and animal source
Q49376241Antibacterial effect evaluation of moxalactam against extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae with in vitro pharmacokinetics/pharmacodynamics simulation
Q90671268Antibiotic Resistance Profile and Diversity of Subtypes Genes in Escherichia coli Causing Bloodstream Infection in Northern Vietnam
Q35634083Antibiotic Resistance in Neonatal Intensive Care Unit Pathogens: Mechanisms, Clinical Impact, and Prevention Including Antibiotic Stewardship
Q34456773Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment
Q33842030Antibiotic resistance genes in the bacteriophage DNA fraction of environmental samples.
Q37291366Antibiotic resistance in the absence of antimicrobial use: mechanisms and implications.
Q39092050Antibiotic resistance in wastewater: occurrence and fate of Enterobacteriaceae producers of class A and class C β-lactamases.
Q34299012Antibiotic selection of Escherichia coli sequence type 131 in a mouse intestinal colonization model
Q35115778Antibiotic treatment of acute uncomplicated cystitis based on rapid urine test and local epidemiology: lessons from a primary care series
Q94500513Antibiotics alone as an alternative to appendectomy for uncomplicated acute appendicitis in adults: Changes in treatment modalities related to the COVID-19 health crisis
Q36595848Antibiotics as selectors and accelerators of diversity in the mechanisms of resistance: from the resistome to genetic plasticity in the β-lactamases world
Q51547630Antibiotics involved in the occurrence of antibiotic-resistant bacteria: a nationwide multilevel study suggests differences within antibiotic classes.
Q36075871Antimicrobial Peptide Novicidin Synergizes with Rifampin, Ceftriaxone, and Ceftazidime against Antibiotic-Resistant Enterobacteriaceae In Vitro.
Q92505594Antimicrobial Resistance Factors of Extended-Spectrum Beta-Lactamases Producing Escherichia coli and Klebsiella pneumoniae Isolated from Cattle Farms and Raw Beef in North-West Province, South Africa
Q40323965Antimicrobial Resistance and Molecular Characterization of Extended-Spectrum β-Lactamases and Other Escherichia coli Isolated from Food of Animal Origin and Human Intestinal Isolates
Q91829224Antimicrobial Resistance and Resistance Determinant Insights into Multi-Drug Resistant Gram-Negative Bacteria Isolates from Paediatric Patients in China
Q93048432Antimicrobial Resistance, Virulence Factors, and Pathotypes of Escherichia coli Isolated from Drinking Water Sources in Jordan
Q40047461Antimicrobial Susceptibility Pattern of Extended-spectrum Beta-lactamases Producing Organisms Isolated in a Tertiary Care Hospital, Bangladesh
Q36570484Antimicrobial drug-resistant Escherichia coli in wild birds and free-range poultry, Bangladesh
Q47792770Antimicrobial resistance among children in sub-Saharan Africa.
Q37119884Antimicrobial resistance in urosepsis: outcomes from the multinational, multicenter global prevalence of infections in urology (GPIU) study 2003-2013.
Q37356539Antimicrobial resistance in zoonotic bacteria: lessons learned from host-specific pathogens
Q33760545Antimicrobial resistance patterns, clinical features, and risk factors for septic shock and death of nosocomial E coli bacteremia in adult patients with hematological disease: A monocenter retrospective study in China
Q30377725Antimicrobial resistance profiles and molecular characterization of Escherichia coli strains isolated from healthy adults in Ho Chi Minh City, Vietnam.
Q64901592Antimicrobial resistance trends in bloodstream infections at a large teaching hospital in China: a 20-year surveillance study (1998-2017).
Q28485932Antimicrobial resistance, virulence factors and genetic diversity of Escherichia coli isolates from household water supply in Dhaka, Bangladesh
Q55444694Antimicrobial susceptibility of gram-negative bacilli isolated from intra-abdominal and urinary-tract infections in Mexico from 2009 to 2015: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART).
Q37704754Antimicrobial susceptibility of uropathogens isolated from Cambodian children
Q33834243Antimicrobial susceptibility pattern of extended-spectrum β-lactamase-producing bacteria causing nosocomial urinary tract infections in an Iranian referral teaching hospital
Q40622938Antimicrobial-resistant Escherichia coli in hospitalised companion animals and their hospital environment
Q35135491Antimicrobials increase travelers' risk of colonization by extended-spectrum betalactamase-producing Enterobacteriaceae.
Q26739860Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA).
Q35408392Application of swine manure on agricultural fields contributes to extended-spectrum β-lactamase-producing Escherichia coli spread in Tai'an, China
Q34426513Aspergillomarasmine A overcomes metallo-β-lactamase antibiotic resistance
Q64258452Assessing Molecular Epidemiology of Carbapenem-resistant Klebsiella pneumoniae (CR-KP) with MLST and MALDI-TOF in Central China
Q37466572Assessment of extended-spectrum β-lactamases and integrons among Enterobacteriaceae in device-associated infections: multicenter study in north of Iran.
Q37120182Assessment of the In Vitro Activity of Ceftazidime-Avibactam against Multidrug-Resistant Klebsiella spp. Collected in the INFORM Global Surveillance Study, 2012 to 2014
Q99712409Assessment of urinary pharmacokinetic and pharmacodynamic profiles of faropenem against extended-spectrum β-lactamase-producing Escherichia coli with canine ex vivo modelling: a pilot study
Q60309718Association between Beta-lactam Antibiotic Resistance and Virulence Factors in AmpC Producing Clinical Strains of
Q41072200Association between Virulence Factors and Extended Spectrum Beta-Lactamase Producing Klebsiella pneumoniae Compared to Nonproducing Isolates.
Q92792026Attributable sources of community-acquired carriage of Escherichia coli containing β-lactam antibiotic resistance genes: a population-based modelling study
Q54341490Bacterial sepsis following prostatic biopsy.
Q40781932Bacteriology and antimicrobial susceptibility of ESBLs producers from pus in patients with abdominal trauma associated intra-abdominal infections
Q37240274Bacteriophage tailspike protein based assay to monitor phase variable glucosylations in Salmonella O-antigens
Q89543255Bacterioplankton community variation in Bohai Bay (China) is explained by joint effects of environmental and spatial factors
Q29616084Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America
Q33673654Bloodstream infections and sepsis in Greece: over-time change of epidemiology and impact of de-escalation on final outcome
Q36870786Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy
Q26795565Bloodstream infections in intensive care unit patients: distribution and antibiotic resistance of bacteria
Q38694666Bloodstream infections in internal medicine.
Q26765868Breaking the Spell: Combating Multidrug Resistant 'Superbugs'
Q30415141CTX-M Enzymes: Origin and Diffusion
Q42574879CTX-M as the predominant extended-spectrum beta-lactamases among Enterobacteriaceae in Manila, Philippines
Q34603776CTX-M beta-lactamase production and virulence of Escherichia coli K1
Q37053548CTX-M extended-spectrum β-lactamase-producing Klebsiella spp, Salmonella spp, Shigella spp and Escherichia coli isolates in Iranian hospitals.
Q55154197CTX-M-15 is Established in Most Multidrug-Resistant Uropathogenic Enterobacteriaceae and Pseudomonaceae from Hospitals in Nigeria.
Q46283648CTX-M-15-producing Shewanella sp. clinical isolate expressing OXA-535, a chromosome-encoded OXA-48 variant, putative progenitor of the plasmid-encoded OXA-436.
Q37538628CTX-M-190, a Novel β-Lactamase Resistant to Tazobactam and Sulbactam, Identified in an Escherichia coli Clinical Isolate.
Q35134784CTX-M-2-producing Salmonella Typhimurium isolated from pediatric patients and poultry in Brazil
Q54413749Capsular polysaccharide and the O-specific antigen impede antibody binding: a potential obstacle for the successful development of an extraintestinal pathogenic Escherichia coli vaccine.
Q36212092Carbapenem-Resistant Enterobacteriaceae in Children, United States, 1999-2012.
Q38152302Carbapenem-Resistant Enterobacteriaceae: Laboratory Detection and Infection Control Practices
Q27002495Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamases: a systematic review and meta-analysis
Q89849315Catheter-Related ESBL-Producing Leclercia adecarboxylata Septicemia in Hemodialysis Patient: An Emerging Pathogen?
Q36973200Causative Organisms and Associated Antimicrobial Resistance in Healthcare-Associated, Central Line-Associated Bloodstream Infections From Oncology Settings, 2009-2012.
Q36878269Causes, consequences, and perspectives in the variations of intestinal density of colonization of multidrug-resistant enterobacteria.
Q45341557Cefepime therapy for monomicrobial bacteremia caused by cefepime-susceptible extended-spectrum beta-lactamase-producing Enterobacteriaceae: MIC matters
Q33598276Cefepime vs other antibacterial agents for the treatment of Enterobacter species bacteremia
Q36438937Cefotaxime and Amoxicillin-Clavulanate Synergism against Extended-Spectrum-β-Lactamase-Producing Escherichia coli in a Murine Model of Urinary Tract Infection
Q33816309Cefotaxime-resistant Salmonella enterica in travelers returning from Thailand to Finland
Q34244192Cefoxitin as an alternative to carbapenems in a murine model of urinary tract infection due to Escherichia coli harboring CTX-M-15-type extended-spectrum β-lactamase.
Q38740494Ceftazidime-avibactam: novel antimicrobial combination for the treatment of complicated urinary tract infections
Q39037981Ceftolozane/tazobactam for the treatment of complicated urinary tract and intra-abdominal infections.
Q48274228Ceftriaxone promotes the emergence of AmpC-overproducing Enterobacteriaceae in gut microbiota from hospitalized patients
Q54379378Cephalosporin and fluoroquinolone combinations are highly associated with CTX-M β-lactamase-producing Escherichia coli: a case–control study in a French teaching hospital
Q92918587Change in the Annual Antibiotic Susceptibility of Escherichia coli in Community-Onset Urinary Tract Infection between 2008 and 2017 in a Tertiary Care Hospital in Korea
Q90115946Change in the Antimicrobial Resistance Profile of Extended-Spectrum β-Lactamase-Producing Escherichia coli
Q44678593Change in the prevalence of extended-spectrum-beta-lactamase-producing Escherichia coli in Japan by clonal spread
Q41773965Changing epidemiology of infections due to extended spectrum beta-lactamase producing bacteria
Q64106427Changing paradigm of antibiotic resistance amongst Escherichia coli isolates in Indian pediatric population
Q40214475Changing trends in the aetiology, treatment and outcomes of bloodstream infection occurring in the first year after solid organ transplantation: a single-centre prospective cohort study.
Q40410184Characterisation of extended-spectrum β-lactamase and AmpC β-lactamase-producing Enterobacteriaceae isolated from companion animals in New Zealand
Q37025251Characteristics and management of Enterobacteriaceae harboring IMP-4 or IMP-8 carbapenemase in a tertiary hospital
Q33798233Characteristics of Escherichia coli sequence type 131 isolates that produce extended-spectrum β-lactamases: global distribution of the H30-Rx sublineage
Q36294435Characteristics of extended-spectrum β-lactamase-producing Escherichia coli isolated from fecal samples of piglets with diarrhea in central and southern Taiwan in 2015
Q41747974Characterization and Antimicrobial Activity of Volatile Constituents from Fresh Fruits of Alchornea cordifolia and Canthium subcordatum
Q54291041Characterization of CTX-M-producing Escherichia coli by repetitive sequence-based PCR and real-time PCR-based replicon typing of CTX-M-15 plasmids.
Q36708459Characterization of Extended-Spectrum Beta-lactamase from Escherichia coli and Klebsiella Species from North Eastern Nigeria
Q40323915Characterization of Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolates from Pigs and Farm Workers
Q35747796Characterization of Fosfomycin Resistant Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolates from Human and Pig in Taiwan
Q42654284Characterization of Four Multidrug Resistance Plasmids Captured from the Sediments of an Urban Coastal Wetland
Q35833277Characterization of Piperacillin/Tazobactam-Resistant Klebsiella oxytoca Recovered from a Nosocomial Outbreak
Q40890558Characterization of a CTX-M-15 Producing Klebsiella Pneumoniae Outbreak Strain Assigned to a Novel Sequence Type (1427).
Q46804744Characterization of a Large Antibiotic Resistance Plasmid Found in Enteropathogenic Escherichia coli Strain B171 and Its Relatedness to Plasmids of Diverse E. coli and Shigella Strains
Q40330733Characterization of a novel metallo-β-lactamases fold hydrolase from Pelagibacterium halotolerans, a marine halotolerant bacterium isolated from East China Sea.
Q54307580Characterization of antibiotic-resistance genes in antibiotic resistance Escherichia coli isolates from a lake.
Q54240932Characterization of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae from Riyadh, Saudi Arabia.
Q35940783Characterization of extended-spectrum β-lactamase genes found among Escherichia coli isolates from duck and environmental samples obtained on a duck farm
Q37026386Characterization of extended-spectrum-beta-lactamase-producing Escherichia coli strains involved in maternal-fetal colonization: prevalence of E. coli ST131.
Q37639669Characterization of integrons among Escherichia coli in a region at high incidence of ESBL-EC.
Q52300037Characterization of plasmids encoding extended-spectrum β-lactamases and their addiction systems circulating among Escherichia coli clinical isolates in the UK.
Q53765869Childhood urinary tract infection caused by extended-spectrum β-lactamase-producing bacteria: Risk factors and empiric therapy.
Q40131042Clinical Characteristics of Bacteremia Caused by Extended-spectrum Beta-lactamase-producing Escherichia coli at a Tertiary Hospital
Q37705545Clinical Efficacy of Ertapenem for Recurrent Cystitis Caused by Multidrug-Resistant Extended-Spectrum β-Lactamase-Producing Escherichia coli in Female Outpatients
Q26781236Clinical and Molecular Epidemiology of Extended-Spectrum Beta-Lactamase-Producing Klebsiella spp.: A Systematic Review and Meta-Analyses
Q35867321Clinical and microbiologic characteristics of cephalosporin-resistant Escherichia coli at three centers in the United States
Q38970658Clinical and microbiological determinants of severe and fatal outcomes in patients infected with Enterobacteriaceae producing extended-spectrum β-lactamase.
Q35065929Clinical and molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli causing bacteremia in the Rotterdam Area, Netherlands
Q46544388Clinical and molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a long-term study from Japan
Q50997686Clinical characteristics and outcomes of patients with extended-spectrum β-lactamase-producing bacteremias in the emergency department.
Q54315149Clinical characteristics of community-acquired acute pyelonephritis caused by ESBL-producing pathogens in South Korea.
Q90102788Clinical effectiveness of oral antimicrobial therapy for acute pyelonephritis caused by extended-spectrum β-lactamase-producing Enterobacteriales
Q37612207Clinical efficacy of β-lactam/β-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum β-lactamase-producing Enterobacteriaceae in haematological patients with neutropaenia: a study protocol for a retros
Q35607768Clinical epidemiology and molecular analysis of extended-spectrum-β-lactamase-producing Escherichia coli in Nepal: characteristics of sequence types 131 and 648
Q33566287Clinical outcome of empiric antimicrobial therapy of bacteremia due to extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae
Q90182107Clinical outcomes of ceftazidime-avibactam in lung transplant recipients with infections caused by extensively drug-resistant gram-negative bacilli
Q53684270Clinical patterns, epidemiology and risk factors of community-acquired urinary tract infection caused by extended-spectrum beta-lactamase producers: a prospective hospital case-control study.
Q46247265Clinical predictive values of extended-spectrum beta-lactamase carriage in patients admitted to medical wards
Q33791265Clinical profiles of patients colonized or infected with extended-spectrum beta-lactamase producing Enterobacteriaceae isolates: a 20 month retrospective study at a Belgian University Hospital
Q44171558Clinical significance of infections caused by plasmid-mediated AmpC β-lactamases and extended-spectrum β-lactamase-producing Escherichia coli
Q94545197Clinically Relevant Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolates From Food Animals in South Korea
Q36505381Clonal structure, extended-spectrum β-lactamases, and acquired AmpC-type cephalosporinases of Escherichia coli populations colonizing patients in rehabilitation centers in four countries
Q64912631Close proximity interactions support transmission of ESBL-K. pneumoniae but not ESBL-E. coli in healthcare settings.
Q35306037Co-existence of beta-lactamases in clinical isolates of Escherichia coli from Kathmandu, Nepal
Q41201549Co-prevalance of PMQR and 16S rRNA methylase genes in clinical Escherichia coli isolates with high diversity of CTX-M from diseased farmed pigeons
Q37599342Colicin E2 Expression in Lactobacillus brevis DT24, A Vaginal Probiotic Isolate, against Uropathogenic Escherichia coli
Q89456253Colistin-resistant Escherichia coli carrying mcr-1 in food, water, hand rinse, and healthy human gut in Bangladesh
Q38185120Colonization and infection with extended spectrum beta-lactamase producing Enterobacteriaceae in high-risk patients - Review of the literature from a clinical perspective.
Q41866259Colorimetric-plate method for rapid disk diffusion susceptibility testing of Escherichia coli.
Q37798897Combating evolution with intelligent design: the neoglycoside ACHN-490
Q53797688Combinations of mutations in envZ, ftsI, mrdA, acrB and acrR can cause high-level carbapenem resistance in Escherichia coli.
Q35559648Community acquired multi-drug resistant clinical isolates of Escherichia coli in a tertiary care center of Nepal.
Q42558984Community-associated Escherichia coli harboring CTX-M β-lactamases from urine cultures from pediatric patients
Q35552650Comparable outcomes for β-lactam/β-lactamase inhibitor combinations and carbapenems in definitive treatment of bloodstream infections caused by cefotaxime-resistant Escherichia coli or Klebsiella pneumoniae
Q92620234Comparative Genome-Scale Metabolic Modeling of Metallo-Beta-Lactamase-Producing Multidrug-Resistant Klebsiella pneumoniae Clinical Isolates
Q35005608Comparative analysis of ESBL-positive Escherichia coli isolates from animals and humans from the UK, The Netherlands and Germany
Q43130173Comparative analysis of extended-spectrum-{beta}-lactamase-carrying plasmids from different members of Enterobacteriaceae isolated from poultry, pigs and humans: evidence for a shared {beta}-lactam resistance gene pool?
Q38681779Comparison Between Carbapenems and β-Lactam/β-Lactamase Inhibitors in the Treatment for Bloodstream Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: A Systematic Review and Meta-Analysis
Q35082753Comparison of ESBL--and AmpC producing Enterobacteriaceae and methicillin-resistant Staphylococcus aureus (MRSA) isolated from migratory and resident population of rooks (Corvus frugilegus) in Austria
Q92327785Comparison of Four Commercial Screening Assays for the Detection of blaKPC, blaNDM, blaIMP, blaVIM, and blaOXA48 in Rectal Secretion Collected by Swabs
Q40874147Comparison of Three Biochemical Tests for Rapid Detection of Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae
Q41433212Comparison of community-onset healthcare-associated and hospital-acquired urinary infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and antimicrobial activities
Q41893419Comparison of five media for detection of extended-spectrum Beta-lactamase by use of the wasp instrument for automated specimen processing
Q34995541Comparison of host response mechanisms evoked by extended spectrum beta lactamase (ESBL)--and non-ESBL-producing uropathogenic E. coli
Q28474528Complete nucleotide sequence of CTX-M-15-plasmids from clinical Escherichia coli isolates: insertional events of transposons and insertion sequences
Q42047074Complete nucleotide sequence of plasmid pTN48, encoding the CTX-M-14 extended-spectrum β-lactamase from an Escherichia coli O102-ST405 strain
Q35607920Complete nucleotide sequences of bla(CTX-M)-harboring IncF plasmids from community-associated Escherichia coli strains in the United States
Q53704735Comprehensive Molecular Characterization of Escherichia coli Isolates from Urine Samples of Hospitalized Patients in Rio de Janeiro, Brazil.
Q45739887Consequences of revised CLSI and EUCAST guidelines for antibiotic susceptibility patterns of ESBL- and AmpC β-lactamase-producing clinical Enterobacteriaceae isolates
Q41004466Considerations About Antimicrobial Stewardship in Settings with Epidemic Extended-Spectrum β-Lactamase-Producing or Carbapenem-Resistant Enterobacteriaceae
Q34150900Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy
Q33652427Cotrimoxazole - optimal dosing in the critically ill.
Q40337340Cranberry capsules to prevent nosocomial urinary tract bacteriuria after pelvic surgery: a randomised controlled trial.
Q27670888Crystal structure of New Delhi metallo-β-lactamase reveals molecular basis for antibiotic resistance
Q98159642Current Status and Prospects of Spontaneous Peritonitis in Patients with Cirrhosis
Q24612271Current concepts in antimicrobial therapy against resistant gram-negative organisms: extended-spectrum beta-lactamase-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa
Q37720801Cyclic Boronates Inhibit All Classes of β-Lactamases
Q34299058Deletion mutations conferring substrate spectrum extension in the class A β-lactamase.
Q59810354Descriptive Epidemiology of Acute Pyelonephritis in Korea, 2010-2014: Population-based Study
Q51733061Designing Superoxide-Generating Quantum Dots for Selective Light-Activated Nanotherapy.
Q40682992Detection and characterization of extended-spectrum β-lactamase-producing Escherichia coli from chicken production chains in Nigeria
Q36641097Detection and characterization of extended-spectrum β-lactamases (blaCTX-M-1 and blaSHV ) producing Escherichia coli, Salmonella spp. and Klebsiella pneumoniae isolated from humans in Mizoram
Q40095174Detection of CTX-M-15 Among Uropathogenic Escherichia coli Isolated from Five Major Hospitals in Tripoli, Libya
Q42127782Detection of CTX-M-type extended-spectrum beta-lactamase (ESBLs) by testing with MicroScan overnight and ESBL confirmation panels
Q41087121Detection of Extended-Spectrum β-Lactamase and Plasmid-Mediated Quinolone Resistance Determinants in Escherichia coli Isolates from Retail Meat in China
Q36087090Detection of Healthcare-Related Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Transmission Events Using Combined Genetic and Phenotypic Epidemiology
Q41971522Detection of a CTX-M group 2 beta-lactamase gene in a Klebsiella pneumoniae isolate from a tertiary care hospital, Trinidad and Tobago
Q42280677Detection of carbapenemase producers in Enterobacteriaceae by use of a novel screening medium
Q42933170Detection of extended-spectrum β-lactamases in Klebsiella pneumoniae: comparison of phenotypic characterization methods.
Q37546694Detection of resistance to beta-lactamase inhibitors in strains with CTX-M beta-lactamases: a multicenter external proficiency study using a well-defined collection of Escherichia coli strains.
Q42258248Detection, treatment, and prevention of carbapenemase-producing Enterobacteriaceae: recommendations from an International Working Group.
Q33901083Development and validation of a resistance and virulence gene microarray targeting Escherichia coli and Salmonella enterica
Q53083132Development of a Luminex xTAG® assay for cost-effective multiplex detection of β-lactamases in Gram-negative bacteria.
Q90151752Development of a Two Triplex Real-Time Polymerase Chain Reaction for Rapid Detection of Six Carbapenemase Genes in Enterobacteriaceae
Q41143762Development of a multiplex PCR system and its application in detection of blaSHV, blaTEM, blaCTX-M-1, blaCTX-M-9 and blaOXA-1 group genes in clinical Klebsiella pneumoniae and Escherichia coli strains
Q33916223Development of a multiplex real-time PCR for the rapid detection of the predominant beta-lactamase genes CTX-M, SHV, TEM and CIT-type AmpCs in Enterobacteriaceae
Q61818375Diarrheal bacterial pathogens and multi-resistant enterobacteria in the Choqueyapu River in La Paz, Bolivia
Q34198942Differences in risk-factor profiles between patients with ESBL-producing Escherichia coli and Klebsiella pneumoniae: a multicentre case-case comparison study
Q33466737Differential regulation of horizontally acquired and core genome genes by the bacterial modulator H-NS.
Q34402917Discrepancy between effects of carbapenems and flomoxef in treating nosocomial hemodialysis access-related bacteremia secondary to extended spectrum beta-lactamase producing Klebsiella pneumoniae in patients on maintenance hemodialysis
Q40517201Distribution of ESBLs, AmpC β-lactamases and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal and urinary tract infections in the Asia-Pacific region during 2008-14: results from the Study for Monitoring Antimicrobial Resista
Q36969909Distribution of extended-spectrum β-lactamases, AmpC β-lactamases, and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific region: results of the study for Monitoring Antimicrobial Resistance Trend
Q89449909Diversity among blaKPC-containing plasmids in Escherichia coli and other bacterial species isolated from the same patients
Q30389929Diversity of Escherichia coli strains producing extended-spectrum beta-lactamases in Spain: second nationwide study
Q54340237Diversity of extended-spectrum β-lactamase-producing Enterobacteriaceae on hospital admission.
Q92970844Diversity, Virulence, and Clinical Significance of Extended-Spectrum β-Lactamase- and pAmpC-Producing Escherichia coli From Companion Animals
Q60053842Duration of Colonization by Extended-Spectrum β-Lactamase-Producing in Healthy Newborns and Associated Risk Factors: A Prospective Cohort Study
Q40219287ESBL carriage in pig slaughterhouse workers is associated with occupational exposure.
Q61818384ESBL colonization and acquisition in a hospital population: The molecular epidemiology and transmission of resistance genes
Q35101453ESBLs: A Clear and Present Danger?
Q37544901Early-onset neonatal sepsis.
Q57055898Effect and Safety of Meropenem-Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial
Q61727885Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial
Q33534910Effect of ethnomedicinal plants used in folklore medicine in Jordan as antibiotic resistant inhibitors on Escherichia coli
Q34701924Efficacy of admission screening for extended-spectrum beta-lactamase producing Enterobacteriaceae
Q90071190Efficacy of cefoxitin versus carbapenem in febrile male urinary tract infections caused by extended spectrum beta-lactamase-producing Escherichia coli: a multicenter retrospective cohort study with propensity score analysis
Q35867313Efficacy of ertapenem for treatment of bloodstream infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae.
Q41786410Efficient direct extended-spectrum β-lactamase detection by multiplex real-time PCR: accurate assignment of phenotype by use of a limited set of genetic markers
Q60300553Emergence and molecular characterization of multidrug-resistant isolates harboring extended-spectrum β-lactamases causing ventilator-associated pneumonia in China
Q59336637Emergence of high drug resistant bacterial isolates from patients with health care associated infections at Jimma University medical center: a cross sectional study
Q36667172Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients
Q42331477Emerging Perils of Extended Spectrum β-Lactamase Producing Enterobacteriaceae Clinical Isolates in a Teaching Hospital of Nepal
Q38088261Emerging resistance problems and future perspectives in pharmacotherapy for complicated urinary tract infections
Q35539847Emissions of Escherichia coli carrying extended-spectrum β-lactamase resistance from pig farms to the surrounding environment
Q41987129Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Results From the INCREMENT Cohort
Q21146707Empiric therapy for hospital-acquired, Gram-negative complicated intra-abdominal infection and complicated urinary tract infections: a systematic literature review of current and emerging treatment options
Q38749799Enhanced understanding of the host-pathogen interaction in sepsis: new opportunities for omic approaches.
Q48670663Enhancing antibiotic activity to combat resistant Gram-negative bacteria: what's next?
Q43117801Enrichment broth improved detection of extended-spectrum-beta-lactamase-producing bacteria in throat and rectal surveillance cultures of samples from patients in intensive care units
Q38029012Enterobacter cloacae complex: clinical impact and emerging antibiotic resistance
Q49977272Environmental adaptation and vertical dissemination of ESBL-/pAmpC-producing Escherichia coli in an integrated broiler production chain in the absence of an antibiotic treatment.
Q34575092Epidemic plasmid carrying bla(CTX-M-15) in Klebsiella penumoniae in China
Q35811323Epidemiology and Management of Emerging Drug-Resistant Gram-Negative Bacteria: Extended-Spectrum β-Lactamases and Beyond
Q35644344Epidemiology and characteristics of urinary tract infections in children and adolescents.
Q41195981Epidemiology and emerging resistance in bacterial bloodstream infections in patients with hematologic malignancies
Q37036459Epidemiology and risk factors for isolation of Escherichia coli producing CTX-M-type extended-spectrum β-lactamase in a large U.S. Medical Center.
Q35689050Epidemiology and risk factors of community onset infections caused by extended-spectrum β-lactamase-producing Escherichia coli strains
Q36305006Epidemiology of Carbapenem Resistance among Multi-drug Resistant Enterobacteriaceae in Uganda
Q39638797Epidemiology of Escherichia coli, Klebsiella species, and Proteus mirabilis strains producing extended-spectrum β-lactamases from clinical samples in the Kinki Region of Japan
Q64101197Epidemiology of paediatric gastrointestinal colonisation by extended spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolates in north-west Cambodia
Q36901488Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study
Q39956534Ertapenem-Resistant Enterobacteriaceae Risk Factors for Acquisition and Outcomes
Q34100039Ertapenem-induced reduction in valproate levels: case report and review of the literature
Q40312323Erythromycin oxidation and ERY-resistant Escherichia coli inactivation in urban wastewater by sulfate radical-based oxidation process under UV-C irradiation.
Q64962551Escherichia coli Bloodstream Infections in Patients at a University Hospital: Virulence Factors and Clinical Characteristics.
Q39201659Escherichia coli ST131: a multidrug-resistant clone primed for global domination.
Q43230989Escherichia coli of human and avian origin: detection of clonal groups associated with fluoroquinolone and multidrug resistance in Italy
Q37220795Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans
Q33963663Evaluation of a commercial microarray system for detection of SHV-, TEM-, CTX-M-, and KPC-type beta-lactamase genes in Gram-negative isolates
Q50095632Evaluation of the β-Lacta Test for Detection of Extended-Spectrum-β-Lactamase (ESBL)-Producing Organisms Directly from Positive Blood Cultures by Use of Smudge Plates
Q42872010Evaluation of the βLacta test, a rapid test detecting resistance to third-generation cephalosporins in clinical strains of Enterobacteriaceae.
Q47595845Evolution of conformational dynamics determines the conversion of a promiscuous generalist into a specialist enzyme.
Q28472615Evolutionary trajectories of beta-lactamase CTX-M-1 cluster enzymes: predicting antibiotic resistance
Q89939403Experience With Ceftolozane-Tazobactam for the Treatment of Serious Pseudomonas aeruginosa Infections in Saudi Tertiary Care Center
Q33893632Exploring the inhibition of CTX-M-9 by beta-lactamase inhibitors and carbapenems
Q37564145Exposure assessment of extended-spectrum beta-lactamases/AmpC beta-lactamases-producing Escherichia coli in meat in Denmark
Q82796919Expression of ESBL-like activity in infrequently encountered members of the family Enterobacteriaceae
Q51833801Extended spectrum beta-lactamase carriage state among elderly nursing home residents in Beirut.
Q39233531Extended spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae: critical tools for antibiotic resistance pattern
Q92054933Extended spectrum β-lactamase producing uropathogenic Escherichia coli and the correlation of biofilm with antibiotics resistance in Nepal
Q47965283Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae-Related Urinary Tract Infection in Kidney Transplant Recipients: Risk Factors, Treatment, and Long-Term Outcome.
Q35630038Extended-Spectrum Beta-Lactamases Producing E. coli in Wildlife, yet Another Form of Environmental Pollution?
Q36192755Extended-Spectrum beta (β)-Lactamases and Antibiogram in Enterobacteriaceae from Clinical and Drinking Water Sources from Bahir Dar City, Ethiopia
Q94593498Extended-Spectrum β-Lactamase (ESBL) Genotypes among Multidrug-Resistant Uropathogenic Escherichia coli Clinical Isolates from a Teaching Hospital of Nepal
Q99634804Extended-Spectrum β-Lactamase-Producing Enterobacterales Shedding by Dogs and Cats Hospitalized in an Emergency and Critical Care Department of a Veterinary Teaching Hospital
Q37512490Extended-Spectrum-Beta-Lactamase- and Plasmid-Encoded Cephamycinase-Producing Enterobacteria in the Broiler Hatchery as a Potential Mode of Pseudo-Vertical Transmission.
Q34738249Extended-spectrum Beta-lactamase gene sequences in gram-negative saprophytes on retail organic and nonorganic spinach
Q64247726Extended-spectrum beta-lactamase production and multi-drug resistance among isolated in Addis Ababa, Ethiopia
Q35097441Extended-spectrum beta-lactamase-producing Gram-negative bacteria causing neonatal sepsis in India in rural and urban settings
Q34079113Extended-spectrum beta-lactamase-producing bacteria are not detected in supragingival plaque samples from human fecal carriers of ESBL-producing Enterobacteriaceae
Q45994003Extended-spectrum {beta}-lactamases and AmpC {beta}-lactamases in ceftiofur-resistant Salmonella enterica isolates from food and livestock obtained in Germany during 2003-07.
Q40004163Extended-spectrum β-lactamase CTX-M-15-producing Klebsiella pneumoniae of sequence type ST274 in companion animals
Q90431209Extended-spectrum β-lactamase prevalence and virulence factor characterization of enterotoxigenic Escherichia coli responsible for acute diarrhea in Nepal from 2001 to 2016
Q38191750Extended-spectrum β-lactamase, carbapenemase and AmpC producing Enterobacteriaceae in companion animals.
Q58798150Extended-spectrum β-lactamase-encoding genes are spreading on a wide range of Escherichia coli plasmids existing prior to the use of third-generation cephalosporins
Q35555196Extended-spectrum β-lactamase-producing Enterobacteriaceae in children: old foe, emerging threat
Q54333977Extended-spectrum β-lactamase-producing Enterobacteriaceae: in vitro susceptibility to fosfomycin, nitrofurantoin and tigecycline.
Q54355249Extended-spectrum β-lactamase-producing Escherichia coli strains in the feces of carriers contribute substantially to urinary tract infections in these patients.
Q51445786Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy.
Q37322827Extended-spectrum β-lactamase-producing enterobacteriaceae in community-acquired urinary tract infections in São Luís, Brazil
Q39256669Extensive dissemination of CTX-M-1- and CMY-2-producing Escherichia coli in poultry farms in Tunisia
Q35681590Extraintestinal Pathogenic Escherichia coli: A Combination of Virulence with Antibiotic Resistance
Q38063968Extraintestinal pathogenic Escherichia coli: an update on antimicrobial resistance, laboratory diagnosis and treatment
Q54249766Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
Q39409432Faecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae and Shiga toxin-producing Escherichia coli in asymptomatic nursery children in Lower Saxony (Germany), 2014.
Q54972417Faecal colonization of E. coli and Klebsiella spp. producing extended-spectrum beta-lactamases and plasmid-mediated AmpC in Mozambican university students.
Q64955622Failure of Ciprofloxacin Therapy in the Treatment of Community-Acquired Acute Pyelonephritis caused by In-Vitro Susceptible Escherichia coli Strain Producing CTX-Type Extended-Spectrum β-Lactamase.
Q30433281Fatal cross infection by carbapenem-resistant Klebsiella in two liver transplant recipients
Q48165659Febrile urinary-tract infection due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in children: A French prospective multicenter study.
Q38824989Fecal Colonization With Extended-spectrum Beta-lactamase-Producing Enterobacteriaceae and Risk Factors Among Healthy Individuals: A Systematic Review and Metaanalysis
Q64084699Fecal Colonization With Multidrug-Resistant Among Healthy Infants in Rural Bangladesh
Q34532665Fecal carriage of ESBL-producing E. coli and K. pneumoniae in children in Guinea-Bissau: a hospital-based cross-sectional study
Q38461358Fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in Korean community and hospital settings
Q38893310Fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in community setting in Casablanca.
Q33936856Fecal carriage of extended-spectrum β-lactamases and AmpC-producing Escherichia coli in a Libyan community
Q45950234Fighting the spread of AmpC-hyperproducing Enterobacteriaceae: beneficial effect of replacing ceftriaxone with cefotaxime.
Q33909472First description of an extended-spectrum-beta-lactamase-producing multidrug-resistant Escherichia fergusonii strain in a patient with cystitis.
Q33455526Fitness of Escherichia coli during urinary tract infection requires gluconeogenesis and the TCA cycle
Q94547205Fluorescent Materials With Aggregation-Induced Emission Characteristics for Array-Based Sensing Assay
Q42326525Fluoroquinolone resistance among gram-negative urinary tract pathogens: global smart program results, 2009-2010
Q38848662Fluoroquinolone-resistant Escherichia coli sequence type 131 isolates causing bloodstream infections in a canadian region with a centralized laboratory system: rapid emergence of the H30-Rx sublineage
Q36948797Food and human gut as reservoirs of transferable antibiotic resistance encoding genes
Q34096605Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review.
Q43662701Fosfomycin: efficacy against infections caused by multidrug-resistant bacteria
Q37224528Frequency and characteristics of infections caused by extended-spectrum beta-lactamase-producing organisms in neonates: a prospective cohort study
Q90447899Frequency and molecular epidemiology of class A ESBLs producing Enteroinvasive Escherichia coli (EIEC) isolates among patients with diarrhea
Q36757319Frequent occurrence of extended-spectrum beta-lactamase- and transferable ampc beta-lactamase-producing Escherichia coli on domestic chicken meat in Sweden.
Q35744395Functional metagenomics reveals previously unrecognized diversity of antibiotic resistance genes in gulls
Q43128332Further identification of CTX-M-2 extended-spectrum beta-lactamase in Pseudomonas aeruginosa
Q53745020Genetic Background of β-Lactamases in Enterobacteriaceae Isolates from Environmental Samples.
Q28547890Genetic Environment of Plasmid Mediated CTX-M-15 Extended Spectrum Beta-Lactamases from Clinical and Food Borne Bacteria in North-Eastern India
Q45035824Genetic and phenotypic characterisation of Escherichia coli producing cefotaximase-type extended-spectrum β-lactamases: first evidence of the ST131 clone in cats with urinary infections in Italy
Q28112087Global Escherichia coli Sequence Type 131 Clade with blaCTX-M-27 Gene
Q30836432Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data
Q36337074Global fluoroquinolone resistance epidemiology and implictions for clinical use.
Q35847641Global spread of Carbapenemase-producing Enterobacteriaceae
Q36525333Globally dispersed mobile drug-resistance genes in gram-negative bacterial isolates from patients with bloodstream infections in a US urban general hospital
Q43237187Gram-negative bloodstream infections
Q55091640Guidelines for the treatment of severe acute malnutrition: a systematic review of the evidence for antimicrobial therapy.
Q51347384Heteroresistance to colistin in Klebsiella pneumoniae is triggered by small colony variants sub-populations within biofilms.
Q35869239High Diversity of CTX-M Extended-Spectrum β-Lactamases in Municipal Wastewater and Urban Wetlands
Q92809775High Prevalence of CTX-M Type Extended-Spectrum Beta-Lactamase Genes and Detection of NDM-1 Carbapenemase Gene in Extraintestinal Pathogenic Escherichia coli in Cuba
Q47194286High Prevalence of CTX-M-15-Type ESBL-Producing E. coli from Migratory Avian Species in Pakistan
Q39414358High Rate of Acquisition but Short Duration of Carriage of Multidrug-Resistant Enterobacteriaceae After Travel to the Tropics.
Q34671432High colonization rates of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in Swiss travellers to South Asia- a prospective observational multicentre cohort study looking at epidemiology, microbiology and risk factors
Q33635196High diversity of extended-spectrum beta-lactamase-producing bacteria in an urban river sediment habitat
Q54324569High frequency of co-resistance in CTX-M-producing Escherichia coli to non-beta-lactam antibiotics, with the exceptions of amikacin, nitrofurantoin, colistin, tigecycline, and fosfomycin, in a county of Sweden.
Q64086207High prevalence and characterization of extended-spectrum ß-lactamase producing Enterobacteriaceae in Chadian hospitals
Q92416820High prevalence and diversity of extended-spectrum β-lactamase and emergence of OXA-48 producing Enterobacterales in wildlife in Catalonia
Q35222739High prevalence and risk factors of fecal carriage of CTX-M type extended-spectrum beta-lactamase-producing Enterobacteriaceae from healthy rural residents of Taian, China
Q40541461High prevalence of ESBL-producing Escherichia coli and Klebsiella pneumoniae in community-onset bloodstream infections in China
Q42111425High prevalence of ST131 isolates producing CTX-M-15 and CTX-M-14 among extended-spectrum-beta-lactamase-producing Escherichia coli isolates from Canada
Q34237433High prevalence of antibiotic resistance in commensal Escherichia coli among children in rural Vietnam
Q33630862High prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric unit in Madagascar
Q34133230High prevalence of multidrug resistance in bacterial uropathogens from Kathmandu, Nepal
Q38325523High rate of fecal carriage of extended-spectrum-β-lactamase-producing Escherichia coli in healthy children in Gipuzkoa, northern Spain.
Q42207537High rates of intestinal colonisation with fluoroquinolone-resistant ESBL-harbouring Enterobacteriaceae in hospitalised patients with antibiotic-associated diarrhoea
Q43419221Highly resistant microorganisms in a teaching hospital: the role of horizontal spread in a setting of endemicity
Q89537696How Phages Overcome the Challenges of Drug Resistant Bacteria in Clinical Infections
Q93085303Identification of FosA8, a Plasmid-Encoded Fosfomycin Resistance Determinant from Escherichia coli, and Its Origin in Leclercia adecarboxylata
Q28546573Identification of Outer Membrane and Exoproteins of Carbapenem-Resistant Multilocus Sequence Type 258 Klebsiella pneumoniae
Q35065875Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system
Q39613973Impact of Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae on the outcome of community-onset bacteremic urinary tract infections
Q37974746Impact of ceftriaxone de-restriction on the occurrence of ESBL-positive bacterial strains and antibiotic consumption
Q31102336Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study
Q31151607Impact of national policies on the microbial aetiology of surgical site infections in acute NHS hospitals in England: analysis of trends between 2000 and 2013 using multi-centre prospective cohort data
Q41440864Impact of the MIC of piperacillin-tazobactam on the outcome of patients with bacteremia due to extended-spectrum-β-lactamase-producing Escherichia coli.
Q42141880In Vitro Activities of Ertapenem and Imipenem against Clinical Extended Spectrum Beta-Lactamase-Producing Enterobacteriaceae Collected in Military Teaching Hospital Mohammed V of Rabat
Q42844410In Vitro Activity of Available Antimicrobial Coated Foley Catheters Against Escherichia coli, Including Strains Resistant to Extended Spectrum Cephalosporins
Q58730452In Vitro Activity of Newer and Conventional Antimicrobial Agents, Including Fosfomycin and Colistin, against Selected Gram-Negative Bacilli in Kuwait
Q36571892In Vitro Antimicrobial Activity of a Siderophore Cephalosporin, S-649266, against Enterobacteriaceae Clinical Isolates, Including Carbapenem-Resistant Strains
Q91803627In Vivo Pharmacodynamic Profile of Ceftibuten-Clavulanate Combination against Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in the Murine Thigh Infection Model
Q37389468In vitro Effectiveness of Commercial Bacteriophage Cocktails on Diverse Extended-Spectrum Beta-Lactamase Producing Escherichia coli Strains
Q84464779In vitro activity of plant extracts and alkaloids against clinical isolates of extended-spectrum β-lactamase (ESBL)-producing strains
Q40299737In vitro effect of vaginal lactobacilli on the growth and adhesion abilities of uropathogenic Escherichia coli.
Q38626867In vitro selection of variants resistant to beta-lactams plus beta-lactamase inhibitors in CTX-M beta-lactamases: predicting the in vivo scenario?
Q35666617In vivo comparison of CXA-101 (FR264205) with and without tazobactam versus piperacillin-tazobactam using human simulated exposures against phenotypically diverse gram-negative organisms
Q35166517IncA/C plasmid-mediated spread of CMY-2 in multidrug-resistant Escherichia coli from food animals in China
Q40656286Incidence of urinary tract infections and antibiotic resistance in the outpatient setting: a cross-sectional study
Q46877738Incidence rates of carbapenemase-producing Enterobacteriaceae clinical isolates in France: a prospective nationwide study in 2011-12.
Q42426450Increased frequency of integrons and β-lactamase-coding genes among extraintestinal Escherichia coli isolated with a 7-year interval
Q37270671Increased prevalence of antibiotic-resistant E. coli in gulls sampled in Southcentral Alaska is associated with urban environments
Q37623473Increased waterborne blaNDM-1 resistance gene abundances associated with seasonal human pilgrimages to the upper ganges river
Q92538005Increasing Prevalence of ESBL-Producing Multidrug Resistance Escherichia coli From Diseased Pets in Beijing, China From 2012 to 2017
Q46976114Increasing frequency of gram-positive cocci and gram-negative multidrug-resistant bacteria in spontaneous bacterial peritonitis
Q42277205Increasing prevalence of ciprofloxacin resistance in extended-spectrum-β-lactamase-producing Escherichia coli urinary isolates.
Q97552957Independent, external validation of clinical prediction rules for the identification of extended-spectrum β-lactamase-producing Enterobacterales, University Hospital Basel, Switzerland, January 2010 to December 2016
Q63433699Infecciones por enterobacterias
Q46256441Infections Caused by Antimicrobial Drug-Resistant Saprophytic Gram-Negative Bacteria in the Environment
Q37694529Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choices
Q36390405Inhibitory Effect of Biosynthesized Silver Nanoparticles from Extract of Nitzschia palea Against Curli-Mediated Biofilm of Escherichia coli.
Q31148049Integration of Biomass Formulations of Genome-Scale Metabolic Models with Experimental Data Reveals Universally Essential Cofactors in Prokaryotes
Q45994580Intestinal Carriage of Third-Generation Cephalosporin-Resistant and Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Healthy US Children.
Q35825390Intestinal decolonization of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBL): a retrospective observational study in patients at risk for infection and a brief review of the literature
Q39304670Intracellular toxicity of proline-rich antimicrobial peptides shuttled into mammalian cells by the cell-penetrating peptide penetratin
Q44770831Intrafamilial transmission of extended-spectrum-beta-lactamase-producing Escherichia coli and Salmonella enterica Babelsberg among the families of internationally adopted children
Q36138993KPC-mediated resistance in Klebsiella pneumoniae in two hospitals in Padua, Italy, June 2009-December 2011: massive spreading of a KPC-3-encoding plasmid and involvement of non-intensive care units
Q40833352Key demographic characteristics of patients with bacteriuria due to extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae in a multiethnic community, in North West London
Q37409854Kinetic characterization of GES-22 β-lactamase harboring the M169L clinical mutation.
Q36150730Klebsiella pneumoniae bloodstream infection: epidemiology and impact of inappropriate empirical therapy
Q36165510Klebsiella pneumoniae bloodstream infections at a South African children's hospital 2006-2011, a cross-sectional study
Q36051105Local transmission and global dissemination of New Delhi Metallo-Beta-Lactamase (NDM): a whole genome analysis.
Q36667273Long-Term Colonization by bla(CTX-M)-Harboring Escherichia coli in Healthy Japanese People Engaged in Food Handling
Q34763062Longitudinal monitoring of extended-spectrum-beta-lactamase/AmpC-producing Escherichia coli at German broiler chicken fattening farms
Q41715581Loop-mediated isothermal amplification assay targeting the blaCTX-M9 gene for detection of extended spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae
Q40663198Low Occurrence of Extended-Spectrum β-lactamase-Producing Escherichia coli in Finnish Food-Producing Animals.
Q38087195Management of chemotherapy-induced neutropenic fever
Q54353726Massive increase, spread, and exchange of extended spectrum β-lactamase-encoding genes among intestinal Enterobacteriaceae in hospitalized children with severe acute malnutrition in Niger.
Q35030247Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial.
Q34284603Mini-review: Epidemiology and zoonotic potential of multiresistant bacteria and Clostridium difficile in livestock and food
Q37809057Minor extended-spectrum β-lactamases.
Q35203279Modification of the susceptibility of gram-negative rods producing ESβLS to β-lactams by the efflux phenomenon
Q38857234Modified CLSI extended-spectrum β-lactamase (ESBL) confirmatory test for phenotypic detection of ESBLs among Enterobacteriaceae producing various β-lactamases
Q64236542Molecular Characterization of Extended Spectrum β-lactamase and Carbapenemase Producing from a Tertiary Care Hospital
Q92547760Molecular Epidemiology of Ceftriaxone Non-Susceptible Enterobacterales Isolates in an Academic Medical Center in the United States
Q47128982Molecular Epidemiology of Extended-Spectrum β-Lactamase-Producing Escherichia coli Pathotypes in Diarrheal Children from Low Socioeconomic Status Communities in Bihar, India: Emergence of the CTX-M Type
Q33797958Molecular and epidemiological characterization of IMP-type metallo-β-lactamase-producing Enterobacter cloacae in a Large tertiary care hospital in Japan
Q28728384Molecular characteristics of extended-spectrum beta-lactamases and qnr determinants in Enterobacter species from Japan
Q37504205Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli in Riyadh: emergence of CTX-M-15-producing E. coli ST131.
Q30430793Molecular characteristics of extended-spectrum β-lactamases in clinical isolates from Escherichia coli at a Japanese tertiary hospital
Q37247785Molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections
Q37204201Molecular characteristics of travel-related extended-spectrum-beta-lactamase-producing Escherichia coli isolates from the Calgary Health Region
Q89747930Molecular characterization of Extended-spectrum β lactamase- producing E. coli recovered from community-acquired urinary tract infections in Upper Egypt
Q56517171Molecular characterization of extended spectrum β -lactamases enterobacteriaceae causing lower urinary tract infection among pediatric population
Q34675362Molecular characterization of multidrug-resistant extended-spectrum β-lactamase-producing Enterobacteriaceae isolated in Antananarivo, Madagascar
Q24633808Molecular dissection of an outbreak of carbapenem-resistant enterobacteriaceae reveals Intergenus KPC carbapenemase transmission through a promiscuous plasmid
Q89704623Molecular diversity and profile analysis of virulence-associated genes in some Klebsiella pneumoniae isolates
Q24628782Molecular diversity in mechanisms of carbapenem resistance in paediatric Enterobacteriaceae
Q58696360Molecular epidemiology and clinical features of extended-spectrum beta-lactamase- or carbapenemase-producing Escherichia coli bacteremia in Japan
Q34315040Molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli in the community and hospital in Korea: emergence of ST131 producing CTX-M-15.
Q35689028Molecular epidemiology over an 11-year period (2000 to 2010) of extended-spectrum β-lactamase-producing Escherichia coli causing bacteremia in a centralized Canadian region
Q41456628Molecular typing of uropathogenic Escherichia coli isolated from Korean children with urinary tract infection.
Q64105106Monitoring the antimicrobial susceptibility of Gram-negative organisms involved in intraabdominal and urinary tract infections recovered during the SMART study (Spain, 2016 and 2017)
Q40232475Mortality Due to Nosocomial Infection with Klebsiella pneumoniae ESBL().
Q64135930Mortality attributable to different Klebsiella susceptibility patterns and to the coverage of empirical antibiotic therapy: a cohort study on patients admitted to the ICU with infection
Q55479343Multi-Drug Resistant Coliform: Water Sanitary Standards and Health Hazards.
Q91829300Multi-Drug Resistant Escherichia coli Causing Early-Onset Neonatal Sepsis - a Single Center Experience from China
Q40342728Multicenter Clinical and Molecular Epidemiological Analysis of Bacteremia Due to Carbapenem-Resistant Enterobacteriaceae (CRE) in the CRE Epicenter of the United States
Q35960721Multicenter retrospective study of cefmetazole and flomoxef for treatment of extended-spectrum-β-lactamase-producing Escherichia coli bacteremia
Q36792780Multidrug Resistant CTX-M-Producing Escherichia coli: A Growing Threat among HIV Patients in India
Q39031812Multidrug resistant Enterobacteriaceae in New Zealand: a current perspective.
Q39710822Multidrug-resistant Enterobacteriaceae from indoor air of an urban wastewater treatment plant.
Q42366911Multiple Antibiotic-Resistant, Extended Spectrum-β-Lactamase (ESBL)-Producing Enterobacteria in Fresh Seafood
Q54193787Multiplex real-time PCR probe-based for identification of strains producing: OXA48, VIM, KPC and NDM.
Q37291349Multiresistant Enterobacteriaceae: new threat of an old problem
Q41182987Multiresistant uropathogenic Escherichia coli from a region in India where urinary tract infections are endemic: genotypic and phenotypic characteristics of sequence type 131 isolates of the CTX-M-15 extended-spectrum-β-lactamase-producing lineage
Q47312911Mutual influence of secondary and key drug‐resistance mutations on catalytic properties and thermal stability of TEM‐type β‐lactamases
Q34309458National multicenter study of predictors and outcomes of bacteremia upon hospital admission caused by Enterobacteriaceae producing extended-spectrum beta-lactamases
Q39991540Nationwide survey of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae in the French community setting
Q37767653New definitions of extended-spectrum β-lactamase conferring worldwide emerging antibiotic resistance
Q34212596Nosocomial acquisition of methicillin-resistant Staphyloccocus aureus (MRSA) and extended-spectrum beta-lactamase (ESBL) Enterobacteriaceae in hospitalised patients: a prospective multicenter study.
Q37246801Occurence of ArmA and RmtB Aminoglycoside Resistance 16S rRNA Methylases in Extended-Spectrum β-Lactamases Producing Escherichia coli in Algerian Hospitals
Q54321125Occurrence and characteristics of extended-spectrum-β-lactamase- and AmpC-producing clinical isolates derived from companion animals and horses.
Q35815939Occurrence of CTX-M Producing Escherichia coli in Soils, Cattle, and Farm Environment in France (Burgundy Region).
Q48004158Occurrence of Clinically Important Lineages, Including the Sequence Type 131 C1-M27 Subclone, among Extended-Spectrum-β-Lactamase-Producing Escherichia coli in Wastewater.
Q35852382Occurrence of ESBL-Producing Escherichia coli in Livestock and Farm Workers in Mecklenburg-Western Pomerania, Germany
Q35667775Occurrence of SHV, TEM and CTX-M β-Lactamase Genes Among Enteropathogenic Escherichia coli Strains Isolated From Children With Diarrhea.
Q42672109Occurrence of Salmonella enterica and Escherichia coli in raw chicken and beef meat in northern Egypt and dissemination of their antibiotic resistance markers.
Q39135840Occurrence of bla CTX-M-1, qnrB1 and virulence genes in avian ESBL-producing Escherichia coli isolates from Tunisia
Q47595207Once-daily intramuscular amikacin for outpatient treatment of lower urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli in children
Q59128524One-Dimensional TiO2-B Crystals Synthesised by Hydrothermal Process and Their Antibacterial Behaviour onEscherichia coli
Q38672016Optimizing Antibiotic Dosing Strategies for the Treatment of Gram-negative Infections in the Era of Resistance
Q35132012Oral amoxicillin-clavulanic Acid treatment in urinary tract infections caused by extended-spectrum Beta-lactamase-producing organisms
Q37115833Oral and parenteral therapeutic options for outpatient urinary infections caused by enterobacteriaceae producing CTX-M extended-spectrum beta-lactamases
Q40598375Outbreak of Extended-Spectrum Beta-Lactamase Producing Enterobacter cloacae with High MICs of Quaternary Ammonium Compounds in a Hematology Ward Associated with Contaminated Sinks
Q34298437Outbreak of carbapenem-resistant enterobacteriaceae at a long-term acute care hospital: sustained reductions in transmission through active surveillance and targeted interventions
Q35533202Pathogenic and commensal Escherichia coli from irrigation water show potential in transmission of extended spectrum and AmpC β-lactamases determinants to isolates from lettuce
Q53080242Pathogenic multiple antimicrobial resistant Escherichia coli serotypes in recreational waters of Mumbai, India: a potential public health risk.
Q31047716Patient's origin and lifestyle associated with CTX-M-producing Escherichia coli: a case-control-control study
Q35571382Persistence of a pKPN3-like CTX-M-15-encoding IncFIIK plasmid in a Klebsiella pneumonia ST17 host during two years of intestinal colonization
Q35960788Pharmacodynamics of fosfomycin: insights into clinical use for antimicrobial resistance
Q37773368Pharmacokinetic evaluation of piperacillin-tazobactam
Q41917438Pharmacological study of cefoxitin as an alternative antibiotic therapy to carbapenems in treatment of urinary tract infections due to extended-spectrum-β-lactamase-producing Escherichia coli
Q36055979Phenotypic and Molecular Characterisation of Extended-Spectrum Beta-Lactamase Producing Escherichia coli Obtained from Animal Fecal Samples in Ado Ekiti, Nigeria
Q42379269Phenotypic and genotypic characteristics of ESBL and AmpC producing organisms associated with bacteraemia in Ho Chi Minh City, Vietnam
Q37160150Phenotypical characterization and adhesin identification in Escherichia coli strains isolated from dogs with urinary tract infections
Q35926207Photodynamic inactivation of Klebsiella pneumoniae biofilms and planktonic cells by 5-aminolevulinic acid and 5-aminolevulinic acid methyl ester
Q30354365Phylogenetic Analysis of Enteroaggregative Escherichia coli (EAEC) Isolates from Japan Reveals Emergence of CTX-M-14-Producing EAEC O25:H4 Clones Related to Sequence Type 131
Q92237043Pivmecillinam compared to other antimicrobials for community-acquired urinary tract infections with Escherichia coli, ESBL-producing or not - a retrospective cohort study
Q101226482Plasmid- and strain-specific factors drive variation in ESBL-plasmid spread in vitro and in vivo
Q94563655Plasmid-mediated antibiotic resistance among uropathogens in primigravid women-Hyderabad, India
Q37970757Plasmid-mediated resistance in Enterobacteriaceae: changing landscape and implications for therapy
Q34108740Plasmid-mediated resistance to cephalosporins in Salmonella enterica serovar Typhi
Q36926956Plasmidome-analysis of ESBL-producing escherichia coli using conventional typing and high-throughput sequencing
Q30402058Population Genomic Analysis of 1,777 Extended-Spectrum Beta-Lactamase-Producing Klebsiella pneumoniae Isolates, Houston, Texas: Unexpected Abundance of Clonal Group 307.
Q90645341Population Pharmacokinetic Analyses for Ertapenem in Subjects with a Wide Range of Body Sizes
Q27013639Population-based epidemiology and microbiology of community-onset bloodstream infections
Q40082536Preliminary insights into the occurrence of similar clones of extended-spectrum beta-lactamase-producing bacteria in humans, animals and the environment in Tanzania: A systematic review and meta-analysis between 2005 and 2016.
Q35979859Pretransplant fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae and infection after liver transplant, France
Q47142542Prevalence and Antibiotic Resistance of Non-typhoidal Salmonella Isolated from Raw Chicken Carcasses of Commercial Broilers and Spent Hens in Tai'an, China
Q39814783Prevalence and Risk Factors associated with Extended Spectrum Beta Lactamase Producing Escherichia coli and Klebsiella pneumoniae Isolates in Hospitalized Patients in Kashan (Iran).
Q55365818Prevalence and antimicrobial susceptibility patterns of extended spectrum beta-lactamase producing Entrobacteriaceae in the University of Gondar Referral Hospital environments, northwest Ethiopia.
Q36517575Prevalence and characterization of extended-spectrum beta-lactamases producing Enterobacteriaceae in healthy children and associated risk factors
Q91660294Prevalence and distribution of blaCTX-M, blaSHV, blaTEM genes in extended- spectrum β- lactamase- producing E. coli isolates from broiler farms in the Philippines
Q30401450Prevalence and molecular characterization of extended-spectrum β-lactamase (ESBL) and plasmidic AmpC β-lactamase (pAmpC) producing Escherichia coli in dogs
Q36684170Prevalence and risk factors for carriage of ESBL-producing Enterobacteriaceae in Amsterdam
Q37334691Prevalence and risk factors for extended-spectrum β-lactamase-producing Escherichia coli causing community-onset urinary tract infections in Colombia
Q39375018Prevalence and spread of multidrug-resistant Escherichia coli including ST131 in different patient populations in the Euroregion Meuse-Rhine
Q36857383Prevalence of ESBL-Producing Klebsiella pneumoniae Isolates in Tertiary Care Hospital
Q34129686Prevalence of antibiotic resistant bacteria in healthy adults, foods, food animals, and the environment in selected areas in Thailand
Q42374450Prevalence of antimicrobial resistant Escherichia coli from patients with suspected urinary tract infection in primary care, Denmark
Q91576167Prevalence of extended-spectrum and AmpC β-lactamase-producing Escherichia coli in Dutch dairy herds
Q42978682Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae and trends in antibiotic consumption in a county of Sweden
Q51049695Prevalence of faecal ESBL carriage in the community and in a hospital setting in a county of Southern Sweden.
Q54342147Prevalence of fluoroquinolone-resistant Escherichia coli O25:H4-ST131 (CTX-M-15-nonproducing) strains isolated in Japan.
Q55368723Prevalence of multidrug-resistant Gram-negative pathogens isolated from febrile neutropenic cancer patients with bloodstream infections in Egypt and new synergistic antibiotic combinations.
Q41062335Prevalence of β-Lactamase Producing Escherichia coli from Retail Meat in Turkey
Q35738292Preventing the spread of multidrug-resistant gram-negative pathogens: recommendations of an expert panel of the German Society For Hygiene and Microbiology
Q50878488Prevention, removal and inactivation of Escherichia coli and Staphylococcus aureus biofilms using selected monoterpenes of essential oils.
Q42688454Prolonged febrile illness due to CTX-M-15 extended-spectrum β-lactamase-producing Klebsiella pneumoniae infection in Nigeria
Q43482683Prolonged fecal shedding of CTX-M-15-producing Escherichia coli and recurrent sepsis in a patient after cord blood stem-cell transplantation
Q43759722Prospective evaluation of colonization with extended-spectrum beta-lactamase (ESBL)-producing enterobacteriaceae among patients at hospital admission and of subsequent colonization with ESBL-producing enterobacteriaceae among patients during hospita
Q91865096Psychoactive drug prescription and urine colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae
Q38780024Public health risk of antimicrobial resistance transfer from companion animals.
Q38067695Public health risks of enterobacterial isolates producing extended-spectrum β-lactamases or AmpC β-lactamases in food and food-producing animals: an EU perspective of epidemiology, analytical methods, risk factors, and control options.
Q36742408Quantitative evaluation of extended-spectrum β-lactamase-producing Escherichia coli strains in the wastewater of a French teaching hospital and relation to patient strain
Q28732678RNA-seq based transcriptional map of bovine respiratory disease pathogen "Histophilus somni 2336"
Q30402760Rapid Identification of Different Escherichia coli Sequence Type 131 Clades
Q46298651Rapid detection of ESBL, carbapenemases, MRSA and other important resistance phenotypes within 6-8 h by automated disc diffusion antibiotic susceptibility testing
Q35130334Rapid detection of ESBL-producing Enterobacteriaceae in blood cultures
Q42281130Rapid detection of extended-spectrum-β-lactamase-producing Enterobacteriaceae
Q34030592Rapid detection of urinary tract pathogens using microcalorimetry: principle, technique and first results.
Q40505708Rapid determination of β-lactam antimicrobial resistance in bacteria by a liquid chromatography-mass spectrometry-based method
Q27666903Rational design of oncocin derivatives with superior protease stabilities and antibacterial activities based on the high-resolution structure of the oncocin-DnaK complex
Q91754083Re-evaluating the potential of immunoprophylaxis and/or immunotherapy for infections caused by multidrug resistant Klebsiella pneumoniae
Q40014484Recent changes in the epidemiology and management of extended-spectrum β-lactamase-producing Enterobacteriaceae
Q33987808Rectal carriage of extended-spectrum beta-lactamase-producing gram-negative bacilli in community settings in Madagascar
Q38280071Rectal swab culture-directed antimicrobial prophylaxis for prostate biopsy and risk of postprocedure infection: a cohort study
Q37124242Relative fecal abundance of extended-spectrum-β-lactamase-producing Escherichia coli strains and their occurrence in urinary tract infections in women.
Q41145977Renal Abscess Due to Community-acquired Extended-spectrum β-Lactamase-producing Escherichia coli in a 15-Year-old Girl
Q51545120Resistance is futile: the bacteriocin model for addressing the antibiotic resistance challenge.
Q92579541Resistance mechanisms and molecular epidemiology of carbapenem-nonsusceptible Escherichia coli in Taiwan, 2012-2015
Q63647666Resistance mechanisms and population structure of highly drug resistant Klebsiella in Pakistan during the introduction of the carbapenemase NDM-1
Q37998398Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example
Q37290720Resistant gram-negative infections in the outpatient setting in Latin America
Q39383695Rethinking the composition of a rational antibiotic arsenal for the 21st century
Q64230326Risk Factors Affecting Patterns of Antibiotic Resistance and Treatment Efficacy in Extreme Drug Resistance in Intensive Care Unit-Acquired Klebsiella Pneumoniae Infections: A 5-Year Analysis
Q41948199Risk factors and molecular epidemiology of community-onset extended-spectrum β-lactamase-producing Escherichia coli bacteremia.
Q37559129Risk factors and molecular epidemiology of community-onset, multidrug resistance extended-spectrum β-lactamase-producing Escherichia coli infections
Q92997895Risk factors and outcomes in non-transplant patients with extended-spectrum beta-lactamase-producing Escherichia coli bacteremia: a retrospective study from 2013 to 2016
Q33827095Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli
Q54331987Risk factors associated with extended-spectrum β-lactamase-producing Enterobacteriaceae nosocomial bloodstream infections in a tertiary care hospital: a clinical and molecular analysis.
Q36316418Risk factors for ESBL-producing Escherichia coli on pig farms: A longitudinal study in the context of reduced use of antimicrobials
Q34920553Risk factors for community-acquired urinary tract infections caused by ESBL-producing enterobacteriaceae--a case-control study in a low prevalence country
Q36797179Risk factors for extended-spectrum beta-lactamase-producing Escherichia coli infection in hospitalized patients
Q37203077Risk factors for infections with extended-spectrum beta-lactamase-producing Escherichia coli in a county of Southern Sweden
Q90236140Risk factors for mortality of patients with ceftriaxone resistant E. coli bacteremia receiving carbapenem versus beta lactam/beta lactamase inhibitor therapy
Q54376284Risk factors for, and clinical relevance of, faecal extended-spectrum β-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies.
Q51784460Risk factors in community-acquired urinary tract infections caused by ESBL-producing bacteria in children.
Q41750938Risk factors, outcome and impact of empirical antimicrobial treatment in extended-spectrum β-lactamase-producing Escherichia coli bacteraemia
Q58770648Routine detection of carbapenem-resistant gram-negative bacilli in clinical laboratories. A review of current challenge
Q47150482Scientific Opinion on the public health risks of bacterial strains producing extended-spectrum β-lactamases and/or AmpC β-lactamases in food and food-producing animals
Q44691321Seasonal and ascending trends in the incidence of carriage of extended-spectrum ß-lactamase-producing Escherichia coli and Klebsiella species in 2 German hospitals
Q89815195Seasonality in carriage of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in the general population: a pooled analysis of nationwide cross-sectional studies
Q50097358Selection of ESBL-Producing E. coli in a Mouse Intestinal Colonization Model.
Q64118965Shared Multidrug Resistance Patterns in Chicken-Associated Identified by Association Rule Mining
Q40208472Sites of colonization in hospitalized patients with infections caused by extended-spectrum beta-lactamase organisms: a prospective cohort study.
Q54288940Sites of colonization with extended-spectrum β-lactamases (ESBL)-producing enterobacteriaceae: the rationale for screening.
Q60920536Spontaneous bacterial peritonitis - therapeutic challenges in the era of increasing drug resistance of bacteria
Q41002269Spread of extended-spectrum beta-lactamase-producing Escherichia coli from a swine farm to the receiving river
Q24607946Strategies to minimize antibiotic resistance
Q59377088Stratégies thérapeutiques dans les infections urinaires du nourrisson et de l’enfant
Q28547363Studies of Antibiotic Resistance of Beta-Lactamase Bacteria under Different Nutrition Limitations at the Single-Cell Level
Q49961843Study of pandrug and heavy metal resistance among E. coli from anthropogenically influenced Delhi stretch of river Yamuna
Q88801780Subsequent infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in patients with prior infection or fecal colonization
Q39878469Success of an infection control program to reduce the spread of carbapenem-resistant Klebsiella pneumoniae
Q37912231Surveillance and management of multidrug-resistant microorganisms
Q43118114Survey for beta-lactamase among bacterial isolates from Guangzhou, China hospitals between 2005-2006.
Q42259493Survival in the environment is a possible key factor for the expansion of Escherichia coli strains producing extended-spectrum β-lactamases
Q41272045Susceptibilities of common bacterial isolates from oman to old and new antibiotics
Q90012985Susceptibility of Klebsiella Pneumoniae Isolated from Pus Specimens of Post-Surgery Patients in Medan, Indonesia to Selected Antibiotics
Q41087404Synthetic Enterobacterial Common Antigen (ECA) for the Development of a Universal Immunotherapy for Drug-Resistant Enterobacteriaceae
Q30235041Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae
Q38833839Tackling antimicrobial resistance in lower urinary tract infections: treatment options
Q57174160Tackling the Antibiotic Resistance Caused by Class A -Lactamases through the Use of -Lactamase Inhibitory Protein
Q35131933Targeted screening for third-generation cephalosporin-resistant Enterobacteriaceae carriage among patients admitted to intensive care units: a quasi-experimental study
Q47151937Technical specifications on harmonised epidemiological indicators for biological hazards to be covered by meat inspection of poultry
Q36061308Temporal trends and risks factors for antimicrobial resistant Enterobacteriaceae urinary isolates from outpatients in Guadeloupe
Q35572742Ten-year surveillance of nosocomial bloodstream infections: trends of aetiology and antimicrobial resistance in a comprehensive cancer centre
Q38918357Tetracycline resistance in semi-arid agricultural soils under long-term swine effluent application
Q40439056Tetramethylbenzidine method for monitoring the free available chlorine and microbicidal activity of chlorite-based sanitizers under organic-matter-rich environments
Q42777524The CTX-M-14 plasmid pHK01 encodes novel small RNAs and influences host growth and motility.
Q34431394The CTX-M-15-producing Escherichia coli clone O25b: H4-ST131 has high intestine colonization and urinary tract infection abilities
Q37725893The Efficacy of Isolated Bacteriophages from Pig Farms against ESBL/AmpC-Producing Escherichia coli from Pig and Turkey Farms
Q30855831The Lung is a Host Defense Niche for Immediate Neutrophil-Mediated Vascular Protection.
Q30386217The Pandemic H30 Subclone of Escherichia coli Sequence Type 131 Is Associated With Persistent Infections and Adverse Outcomes Independent From Its Multidrug Resistance and Associations With Compromised Hosts.
Q89761156The Prevalence and Characterization of Extended-Spectrum β-Lactamase- and Carbapenemase-Producing Bacteria from Hospital Sewage, Treated Effluents and Receiving Rivers
Q40672387The Resistant-Population Cutoff (RCOFF): a New Concept for Improved Characterization of Antimicrobial Susceptibility Patterns of Non-Wild-Type Bacterial Populations.
Q47427370The Role of Cefepime in the Treatment of Extended-Spectrum Beta-Lactamase Infections
Q94948537The Role of European Starlings (Sturnus vulgaris) in the Dissemination of Multidrug-Resistant Escherichia coli among Concentrated Animal Feeding Operations
Q58540591The Use of Microbiome Restoration Therapeutics to Eliminate Intestinal Colonization With Multidrug-Resistant Organisms
Q35120750The antibacterial effect of nitric oxide against ESBL-producing uropathogenic E. coli is improved by combination with miconazole and polymyxin B nonapeptide
Q91843293The burden of antimicrobial resistance among urinary tract isolates of Escherichia coli in the United States in 2017
Q30375493The changing epidemiology of hospital outbreaks due to ESBL-producing Klebsiella pneumoniae: the CTX-M-15 type consolidation.
Q38497797The complex epidemiology of extended-spectrum β-lactamase-producing Enterobacteriaceae
Q37815628The continuing crisis in antibiotic resistance
Q46108324The effect of inappropriate therapy on bacteremia by ESBL-producing bacteria.
Q40706134The emerging problem of bacterial resistance in cancer patients; proceedings of a workshop held by MASCC "Neutropenia, Infection and Myelosuppression" Study Group during the MASCC annual meeting held in Berlin on 27-29 June 2013.
Q33686940The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies
Q90101011The higher prevalence of extended spectrum beta-lactamases among Escherichia coli ST131 in Southeast Asia is driven by expansion of a single, locally prevalent subclone
Q43509580The impact of a single ward for cohorting patients with infection due to multidrug-resistant organisms
Q42232753The impact of antibiotic use on the incidence and resistance pattern of extended-spectrum beta-lactamase-producing bacteria in primary and secondary healthcare settings
Q90548170The impact of nephrostomy drainage prior to mini-percutaneous nephrolithotomy in patients with ESBL-positive Escherichia coli
Q42219507The mother as most important risk factor for colonization of very low birth weight (VLBW) infants with extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E).
Q37569749The occurrence of ESBL-producing Escherichia coli carrying aminoglycoside resistance genes in urinary tract infections in Saudi Arabia
Q36651658The prevalence of ESBL-producing Enterobacteriaceae in a nursing home setting compared with elderly living at home: a cross-sectional comparison
Q35507460The prevalence of Escherichia coli strains with extended spectrum beta-lactamases isolated in China
Q38766625The rapid detection of cefotaxime-resistant Enterobacteriaceae by HPLC.
Q34969565The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
Q30300020The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae
Q38017141The role of international travel in the worldwide spread of multiresistant Enterobacteriaceae
Q28474307The sudden dominance of blaCTX-M harbouring plasmids in Shigella spp. Circulating in Southern Vietnam
Q34214749The tandem repeats enabling reversible switching between the two phases of β-lactamase substrate spectrum
Q37549390The tide of antimicrobial resistance and selection
Q34298172The β-Lacta test for direct detection of extended-spectrum-β-lactamase-producing Enterobacteriaceae in urine.
Q42433179Third-generation cephalosporin resistance in gram-negative bacteria in the community: a growing public health concern
Q24646623Three decades of beta-lactamase inhibitors
Q37899640Tigecycline treatment for urinary tract infections: case report and literature review
Q53672275Time to positivity of blood culture association with clinical presentation, prognosis and ESBL-production in Escherichia coli bacteremia.
Q40900561Total Synthesis and Structural Reassignment of Aspergillomarasmine A.
Q33790123Transcriptional Alterations of Virulence-Associated Genes in Extended Spectrum Beta-Lactamase (ESBL)-Producing Uropathogenic Escherichia coli during Morphologic Transitions Induced by Ineffective Antibiotics
Q52695014Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae.
Q95793245Treatment of complicated intra-abdominal infections in the era of multi-drug resistant bacteria
Q38246118Treatment option for sepsis in children in the era of antibiotic resistance
Q38739545Treatment options for extended-spectrum beta-lactamase (ESBL) and AmpC-producing bacteria
Q39310965Treatment strategy for a multidrug-resistant Klebsiella UTI.
Q33826293Treatment with fluoroquinolones or with beta-lactam-beta-lactamase inhibitor combinations is a risk factor for isolation of extended-spectrum-beta-lactamase-producing Klebsiella species in hospitalized patients
Q49582929Trend analysis of bacterial uropathogens and their susceptibility pattern: A 4-year (2013-2016) study from Aseer region, Saudi Arabia
Q56909843Trends in Resistance to Carbapenems and Third-Generation Cephalosporins among Clinical Isolates of Klebsiella pneumoniae in the United States, 1999–2010
Q92908957Trends in antimicrobial resistance of bacterial pathogens in Harare, Zimbabwe, 2012-2017: a secondary dataset analysis
Q34282016Twelve positions in a β-lactamase that can expand its substrate spectrum with a single amino acid substitution
Q98906710Twentieth-century emergence of antimicrobial resistant human- and bovine-associated Salmonella enterica serotype Typhimurium lineages in New York State
Q55114432Ugly bugs in healthy guts! Carriage of multidrug-resistant and ESBL-producing commensal Enterobacteriaceae in the intestine of healthy Nepalese adults.
Q47150305Urgent advice on the public health risk of Shiga-toxin producingEscherichia coliin fresh vegetables
Q37766972Urinary tract infection in children: when to worry
Q41900712Using a commercial DiversiLab semiautomated repetitive sequence-based PCR typing technique for identification of Escherichia coli clone ST131 producing CTX-M-15.
Q40044307Using β-lactam/β-lactamase inhibitors for infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae to slow the emergence of carbapenem-resistant Enterobacteriaceae
Q36668671Validation of Cefazolin as Initial Antibiotic for First Upper Urinary Tract Infection in Children
Q43565864Variability of intestinal colonization with third-generation cephalosporin-resistant Enterobacteriaceae and antibiotic use in intensive care units
Q92821474Variation of effect estimates in the analysis of mortality and length of hospital stay in patients with infections caused by bacteria-producing extended-spectrum beta-lactamases: a systematic review and meta-analysis
Q36292839Very high prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in bacteriemic patients hospitalized in teaching hospitals in Bamako, Mali
Q53691748Virulence determinant and extended spectrum beta-lactamase production in Klebsiella pneumoniae isolated from a tertiary care hospital, South India.
Q42931230When carbapenem-hydrolyzing beta-lactamase Kpc meets Escherichia coli ST131 in France
Q97067535Whole Genome Sequencing and Characterization of Multidrug-Resistant (MDR) Bacterial Strains Isolated From a Norwegian University Campus Pond
Q40064103Whole genome sequencing of ESBL-producing Escherichia coli isolated from patients, farm waste and canals in Thailand
Q91899356Whole genome sequencing of extended-spectrum β-lactamase genes in Enterobacteriaceae isolates from Nigeria
Q58753607Whole-Genome Sequence Analysis of CTX-M Containing Escherichia coli Isolates from Retail Meats and Cattle in the United States
Q41115946Whole-Genome Sequences of Multidrug-Resistant Escherichia coli Strains Sharing the Same Sequence Type (ST410) and Isolated from Human and Avian Sources in Italy
Q64236885Whole-genome sequences of multidrug-resistant Escherichia coli in South-Kivu Province, Democratic Republic of Congo: characterization of phylogenomic changes, virulence and resistance genes
Q84370144Wide dissemination of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella spp. in acute care and rehabilitation hospitals
Q37544721Widespread dissemination of CTX-M-15 genotype extended-spectrum-β-lactamase-producing enterobacteriaceae among patients presenting to community hospitals in the southeastern United States
Q40337526Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies
Q94475209[Antibiotics alone as an alternative to appendectomy for uncomplicated acute appendicitis in adults: changes in treatment modalities related to the COVID-19 health crisis]
Q84127351[Periprosthetic infections following total hip replacement with ESBL-forming bacteria: importance for clinical practice]
Q38643867p1220-CTXM, a pKP048-related IncFIIK plasmid carrying bla CTX-M-14 and qnrB4.
Q38076453β-Lactam antimicrobials: what have you done for me lately?
Q50523195β-Lactam/β-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts.
Q36644786β-Lactamase Characterization of Gram-Negative Pathogens Recovered from Patients Enrolled in the Phase 2 Trials for Ceftazidime-Avibactam: Clinical Efficacies Analyzed against Subsets of Molecularly Characterized Isolates
Q38365280β-lactam and β-lactamase inhibitor combinations in the treatment of extended-spectrum β-lactamase producing Enterobacteriaceae: time for a reappraisal in the era of few antibiotic options?
Q38264182β-lactam/β-lactamase inhibitor combinations: from then to now.
Q51048295β-lactamase producing enterobacteria isolated from surveillance swabs of patients in a cardiac intensive care unit in Rio de Janeiro, Brazil.

Search more.